| Abbott Laboratories |
Abstract
Untitled
|
|
Nigel Borshell, Taskin Ahmed |
|
| AstraZeneca |
Abstract
|
|
Nigel Borshell, Taskin Ahmed |
|
| Bayer Healthcare |
Abstract
|
|
Nigel Borshell, Taskin Ahmed |
|
| Bristol-Myers Squibb |
Abstract
|
|
Nigel Borshell, Taskin Ahmed |
|
| Eli Lilly |
Abstract
|
|
Nigel Borshell, Taskin Ahmed |
|
| GlaxoSmithKline |
Abstract
|
|
Nigel Borshell, Taskin Ahmed |
|
| Johnson & Johnson |
Abstract
|
|
Nigel Borshell, Taskin Ahmed |
|
| Merck & Co |
Abstract
|
|
Nigel Borshell, Taskin Ahmed |
|
| Novartis |
Abstract
|
|
Nigel Borshell, Taskin Ahmed |
|
| Pfizer |
Abstract
|
|
Nigel Borshell, Taskin Ahmed |
|
| Roche |
Abstract
|
|
Nigel Borshell, Taskin Ahmed |
|
| Sanofi |
Abstract
|
|
Nigel Borshell, Taskin Ahmed |
|
| GSK Moves up the M&A Rankings |
Abstract
|
|
Nigel Borshell, Taskin Ahmed |
|